Assyro AI

Orange Book product · Generic (ANDA)

AMPICILLIN SODIUM

AMPICILLIN SODIUM

Generic (ANDA)ANDA 062692DISCN HIKMA

At a glance

Jun 24, 1986

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 24, 1986

    40 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMPICILLIN SODIUM

Strength

EQ 1GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 062692

Product number

004

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMPICILLIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.